Used in neuroscience research to quantify glial fibrillary acidic protein (GFAP) levels in mouse biological samples, this ELISA kit serves as a critical tool for assessing astrocyte activation and neuroinflammation. It is widely applied in studies of traumatic brain injury, neurodegenerative diseases such as Alzheimer's and Parkinson’s, and multiple sclerosis models. Researchers use it to monitor disease progression, evaluate therapeutic interventions, and investigate central nervous system damage in preclinical studies. The kit enables sensitive and specific detection of GFAP, allowing for high-throughput analysis in serum, plasma, brain tissue homogenates, and cell culture supernatants. Its application supports biomarker development for blood-brain barrier integrity and neuronal injury assessment.